Holding tight here. Way more to come. Quarter after quarter of new agreements, fda approval and no dilution . This is going over 1 dollar by end of fourth quarter . Everything here is positive including new hires as we grow and grow. This is in my IRA as I like the long term propects here of a company where growth has just begun and should continue at a rapid pace this avoiding dilution as revenue comes in and becoming profitable which will push us way higher than current levels
News 
Market Data 
Discover 
